European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Defossilization of pharmaceutical manufacturing.

Compounding 97

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

pharmaphorum

SEPTEMBER 30, 2022

This shift enables companies to improve the quality and compliance of the documents and data that make up regulatory submissions and create a data-sharing ecosystem that enhances healthcare. Over the years, pharmaceutical companies seeking product approvals have submitted increasingly vast amounts of information to regulatory agencies.

Documentation 52

Documentation Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

Express Pharma

DECEMBER 13, 2024

Flushing pills down the toilet or tossing them into the trash can result in these drugs contaminating water and soil, spreading across vast areas and entering aquatic food chains.

Compounding 102

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 102

PharmaShots

FEBRUARY 27, 2023

As a renowned chemist, Dr. Senanayake discussed the need to adopt green chemistry in the process of drug development for cost reduction, timely innovation, and generating less waste than the standard process. According to me the main issue faced during the pandemic was the supply chain of pharmaceuticals.

Biosimilars 40

Biosimilars Diabetes Packaging Hospitals 40

Drug Patent Watch

DECEMBER 17, 2024

The Evolving Role of CDMOs in the Pharmaceutical Industry Gone are the days when CDMOs were mere service providers. Today, they’re strategic partners in drug development and manufacturing, offering end-to-end solutions that can make or break a pharmaceutical company’s success.

Drug Development 90

Drug Development Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 90

Pharmaceutical Technology

DECEMBER 6, 2022

Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceutical manufacturing world. Within the small molecule landscape, several trends are shaping the industry’s future, one of the most notable being the rise of high-potency active pharmaceutical ingredients (HPAPIs).

Drug Development 52

Drug Development Dosage Pharmaceutical Manufacturing Communication 52

European Pharmaceutical Review

FEBRUARY 20, 2025

Increased API costs may force some manufacturers to reduce output or exit the market entirely, reducing competition and potentially driving price inflation. For branded pharmaceutical companies, the impact may be less immediate due to their larger profit margins. References 1. Internet] American Hospital Association.

Drug Pricing 20

Drug Pricing Pharmaceutical Manufacturing Generic Medicine Hospitals 20